CXCR4 and cancer: In combination, our pan-cancer solid tumor approach showed that overexpression of CXCR4 or FAP lead to detectable transcriptional changes (in terms of mRNA and miRNA), reflected by gene signatures best distinguishing high- and low-expressing samples in RF models.